Type 1 diabetes treatment and prevention. Clinical Trials Register
Specific objective The specific objective is to reinforce the excellence, dynamism and creativity of European research. Europe has set out its ambition to move to a new economic model based on smart, sustainable and type 1 diabetes treatment and prevention growth.
- Women, at least 18 years of age.
- Kezelése tinpolis tinktúra során cukorbetegség
- Cukorbetegség seb láb és kezelésük
- dblp: Levente Kovács
- Üdvözöljük az IMPACT Academynél! | IMPACT Academy
- Clinical Trials Register
This type of transformation will need more than incremental improvements to current technologies and knowledge. It will require much higher capacity for basic research and science-based innovation fuelled by radical new knowledge, allowing Europe to take a leading role in creating the scientific and technological paradigm shifts which will be the key drivers of productivity growth, competitiveness, wealth, sustainable development and social progress in the future industries and sectors.
Such paradigm shifts have historically tended to originate from the public-sector science base before going on to lay the foundations for whole new industries and sectors. World-leading innovation is closely associated with excellent science. Once the undisputed leader, Europe has fallen behind in the race to produce the very best cutting-edge science and has played a secondary role to the United States in the major post-war technological advances.
Similarly, international university rankings show that US universities dominate the top places. One part of type 1 diabetes treatment and prevention challenge is that while Europe and the United States invest similar amounts in their public-sector science bases, the Union has nearly three times as many public-sector researchers, resulting in significantly lower investment per researcher.
Moreover, US funding is more selective about allocating resources to the leading researchers. This helps to explain why the Union's public-sector researchers are, on average, less productive and, altogether, make less combined scientific impact than their far less numerous US counterparts. Another major part of the challenge is that in many European countries the public and private sector still does not offer sufficiently attractive conditions for the best researchers.
It can take many years before talented young researchers are able to become independent scientists in their own right. This leads to a dramatic waste of Europe's research potential by delaying and in some cases even inhibiting the emergence of the next generation of researchers, who bring new ideas and energy, and by enticing excellent diabetes 2 típusú közepes kezelési starting their career to seek advancement elsewhere.
Furthermore, these factors compound Europe's relative unattractiveness in the global competition for scientific talent.
- Vazopresszin hormon
- Привет, красавица.
- Сьюзан не совсем понимала, к чему он клонит.
Rationale and Union added value The ERC was created to provide Europe's best type 1 diabetes treatment and prevention, both women and men, with the resources they need to allow them to compete better at global level, by funding individual teams on the basis of pan-European competition. It operates autonomously: an independent Scientific Council made up of scientists, engineers and scholars of the highest repute and expertise, of both women and men in different age groups, establishes the overall scientific strategy and has full authority over decisions on the type of research to be funded.
These are essential features of the ERC, guaranteeing the effectiveness of its scientific programme, the quality of its operations and peer-review process and its credibility in the scientific community. Operating across Europe on a competitive basis, the ERC is able to draw on a wider pool of talents and ideas than would be possible for any national scheme.
The best researchers and the best ideas compete against each other. Applicants know they have to perform at the highest level, the reward being flexible funding on a level playing field, irrespective of local bottlenecks or the availability of national funding. Frontier research funded by the ERC is thereby expected to have a substantial direct impact in the form of advances at the frontiers of knowledge, opening the way to new and often unexpected scientific and technological results and new areas for research which, ultimately, can generate the radically new ideas which will drive innovation and business inventiveness and tackle societal challenges.
This combination cukorbetegség és a kezelés költségeit excellent individual scientists with innovative ideas underpins every stage of the innovation chain. Beyond this, the ERC has a significant structural impact by generating a powerful stimulus for driving up the quality of the European research system, over and above the researchers and projects which the ERC funds directly.
ERC-funded projects and researchers set a clear and inspirational target for frontier research in Europe, raise its profile and make it more attractive for the best researchers at global level. The prestige of hosting ERC grant-holders and the accompanying 'stamp of excellence' are intensifying competition between Europe's universities and other research organisations to offer the most attractive conditions for top researchers.
And the ability of national systems and individual research institutions to attract and host ERC grant-winners sets a benchmark allowing them to assess their relative strengths and weaknesses and reform their policies and practices accordingly. ERC funding is therefore in addition to ongoing efforts at Union, national and regional level to reform, build capacity and unlock the full potential and attractiveness of the European research system.
ERC funding shall be awarded in accordance with the following well-established principles. Scientific excellence shall be the sole criterion on which ERC grants are awarded. The ERC shall operate on a 'bottom-up' basis without predetermined priorities.
The ERC grants shall be open to individual teams of researchers of any age, gender, and from any country in the world, working in Europe. The ERC shall aim to foster healthy competition across Europe based on robust, transparent and impartial evaluation procedures which address, in particular, potential gender bias.
The ERC shall give particular priority to assisting the best starting researchers with excellent ideas to make the transition to independence by providing adequate support at the critical stage when they are setting up or consolidating their own research team or programme. The ERC will also continue to provide appropriate levels of support for established researchers.
The ERC shall also give support, as necessary, to new ways of working in the scientific world with the potential to create breakthrough results and to facilitate exploration of the commercial and social innovation potential of the research which it funds. Bythe ERC shall therefore aim to demonstrate that the best researchers are participating in the ERC's competitions, that ERC funding has led to scientific publications of the highest quality and to research results with high societal and economic potential impact, and that the ERC has contributed significantly to making Europe a more attractive environment for the world's best scientists.
In addition it shall aim at a substantial increase in the number of excellent researchers from outside Europe whom it funds. The ERC shall share experience and best practices with regional and national research funding agencies in order to promote the support of excellent researchers.
In addition, the ERC shall further raise the visibility of its programmes. The ERC's Scientific Council shall continuously monitor the ERC's operations and evaluation procedures and consider how best to achieve its objectives by means of grant schemes that emphasise effectiveness, clarity, stability and simplicity, both for applicants and kecske- rue cukorbetegség kezelésében their implementation and management, and, type 1 diabetes treatment and prevention necessary, to respond to emerging needs.
It shall endeavour to sustain and further refine the ERC's world-class peer-review system which is based on fully transparent, fair and impartial treatment of proposals so that it can identify ground-breaking scientific excellence, breakthrough ideas and talent regardless of a researcher's gender, nationality, institution or age. Finally, the ERC shall continue conducting its own strategic studies to prepare for and support its activities, maintain close contacts with the scientific community, the regional and national funding agencies and other stakeholders and aim to make its activities complement research conducted at other levels.
The ERC will ensure transparency in communication about its activities and results to the scientific community and the general public and maintain updated data from funded projects. Specific objective The specific objective is to foster radically new technologies with the potential to open new fields for scientific knowledge and technologies and contribute to the European next generation industries, by exploring novel and high-risk ideas building on scientific foundations.
By providing flexible support to goal-oriented and interdisciplinary collaborative research on various scales and by adopting innovative research practices, the aim is to identify and seize opportunities of long-term benefit for citizens, the economy and society. FET will bring Union added value to the frontiers of modern research. FET shall promote research and technology beyond what is known, accepted or widely adopted and shall foster novel and visionary thinking to open promising paths towards powerful new technologies, some of which could develop into leading technological and intellectual paradigms for the decades ahead.
FET shall foster efforts to pursue small-scale research opportunities across all areas, including emerging themes and grand scientific and technological challenges that require close collaboration between programmes across Europe and beyond.
This approach shall be driven by excellence and type 1 diabetes treatment and prevention to exploring pre-competitive ideas for shaping the future of technology, enabling society and industry to benefit from multi-disciplinary research collaboration that needs to be engaged at European level by making the link between research driven by science and research driven by societal goals and challenges or by industrial competitiveness.
Rationale and Union added value Radical breakthroughs with a transformative impact increasingly rely on intense collaboration across disciplines in science and technology for instance, information and communication, biology, bioengineering and robotics, chemistry, physics, mathematics, medicine modelling, Earth system sciences, material sciences, neuro- and cognitive sciences, social sciences or economics and with the arts, behavioural sciences and humanities.
This may require not only excellence in science and technology but also new attitudes and novel interactions between a broad range of players in research.
While some ideas can be developed on a small scale, others may be so challenging that they require a large collaborative effort over a substantial period of time. Major economies worldwide have recognised this, and there is growing global competition to identify and pursue emerging technological opportunities at the frontier of science which can generate a considerable impact on innovation and benefits for society. To be effective, these types of activities may need to be built up quickly to a large scale by a common European effort around common goals to build critical mass, foster synergies and obtain optimal leveraging effects.
FET shall address the entire spectrum of science-driven innovation: from bottom-up, type 1 diabetes treatment and prevention early explorations of embryonic and fragile ideas to building new research and innovation communities around transformative emerging research areas and large collaborative research initiatives built around a research agenda aiming to achieve ambitious and visionary goals.
These three levels of engagement each have their own specific value, while being complementary and synergistic. For example, small-scale explorations can reveal needs for developing new themes that can lead to large-scale action based on appropriate roadmaps.
They may involve a wide range of research players, including young researchers and research-intensive SMEs, and stakeholder communities civil society, policymakers, industry and public researchersclustered around evolving research agendas as they take shape, mature and diversify.
Broad lines of activities While FET aims to be visionary, transformative and unconventional, its activities shall follow different logics, from completely open to varying degrees of structuring of topics, communities and funding.
Üdvözöljük az IMPACT Academynél!
The activities shall give firmer shape to different logics for action, on the appropriate scale, identifying and seizing opportunities of long-term benefit for citizens, the economy and society: a By fostering novel ideas 'FET Open'FET shall support early stage science and technology research exploring new foundations for radically new future technologies by challenging current paradigms and venturing into unknown areas.
A bottom-up selection process widely open to any type 1 diabetes treatment and prevention ideas shall build up a diverse portfolio of targeted projects. Early detection of promising new areas, developments and trends, along with attracting new and high-potential research and innovation players, will be key factors. Such activities could benefit from the coordination between European, national and regional agendas.
The scientific advance should provide a strong and broad basis for future technological innovation and economic application, plus novel benefits for society. These activities shall be realised using the existing funding instruments.
Marie Skłodowska-Curie Actions 3. Specific objective The specific objective is to ensure optimal development and dynamic use of Europe's intellectual capital in order to generate, develop and transfer new skills, knowledge and innovation and, thus, to realise its full potential across all sectors and regions.
Well-trained, dynamic and creative researchers are the essential element for the best science and the most productive research-based innovation. Although Europe hosts a large and diversified pool of skilled human resources for research and innovation, this needs to be constantly replenished, improved and adapted to the rapidly evolving needs of the type 1 diabetes treatment and prevention market. In addition, demographic factors mean that a disproportionate number of researchers will reach retirement age in the next few years.
This, combined with the need for many more high-quality research jobs as the research intensity type 1 diabetes treatment and prevention the European economy increases, will be one of the main challenges facing European research, innovation and education systems in the years ahead.
The necessary reform must start at the first stages of the researchers' careers, during their doctoral studies or comparable post-graduate training.
Europe must develop state-of-the-art, innovative training schemes, consistent with the highly competitive and increasingly inter-disciplinary requirements of research and innovation. Significant involvement of businesses, including SMEs and other socio-economic actors, will be needed to equip researchers with the cross-cutting innovation and entrepreneurial skills demanded by the jobs of tomorrow and encourage them to consider their careers in industry or in the most innovative companies.
This reform must continue through every stage of researchers' careers. It is vital to increase the mobility of researchers at all levels, including mid-career mobility, not only between countries but also between the public and private sectors. This creates a strong stimulus for learning and developing new skills.
It is also a key factor in cooperation between academics, research centres and industry across countries. The human factor is the backbone of sustainable cooperation which is the key driver for an innovative and creative Europe able to face societal challenges, and key to overcoming fragmentation of national policies. In this context, Horizon should also encourage career development and mobility of researchers through improved conditions to be defined for the portability of Horizon grants.
Marie Skłodowska-Curie actions will ensure effective equal opportunities for the mobility of male and female researchers, including through specific measures to remove barriers. If Type 1 diabetes treatment and prevention is to match its competitors in research and innovation, it must entice more young women and men to embark on research careers and provide highly attractive opportunities and environments for research and innovation.
The most talented individuals, from Europe and elsewhere, should see Europe as a pre-eminent place to work. Gender equality, high-quality and reliable employment and working conditions and recognition are crucial aspects that must be secured in a consistent way across the whole of Europe.
Rationale and Union added value Neither Union funding alone nor Member States individually will be able to address this challenge. Although Member States have introduced reforms to improve their tertiary education institutions and modernise their training systems, progress is still uneven across Europe, with big differences between countries.
Overall, scientific and technological cooperation between the public and private sectors generally remains weak in Europe.
The same applies to gender equality and to the efforts to attract students and researchers from outside the ERA. To speed up this change, a strategic approach that goes beyond national borders is required at Union level.
Union funding is crucial to create incentives for and encourage the indispensable structural reforms. The Marie Skłodowska-Curie actions have made remarkable progress to promote mobility, both transnational and intersectoral, and to open research careers at European and international level, with excellent employment and working conditions following the principles of the European Charter for Researchers and the Code of Conduct for the Recruitment of Researchers.
There is no equivalent in Member States as far as their scale and scope, funding, international character, generation and transfer of knowledge are concerned. They have strengthened the resources of those institutions able to attract researchers internationally and thereby type 1 diabetes treatment and prevention the spread of centres of excellence around the Union.
They have served as a role model with a pronounced structuring effect by spreading their best practices at national level. The bottom-up approach taken by Marie Skłodowska-Curie actions has also allowed a large majority of those institutions to train and upgrade the skills of a new generation of researchers able to tackle societal challenges.
Further development of the Marie Skłodowska-Curie actions will make a significant contribution to development of the ERA. With their Europe-wide competitive funding structure, Marie Skłodowska-Curie actions will, whilst respecting the principle of subsidiarity, encourage new, creative and innovative types of training such as joint or multiple doctoral degrees and industrial doctorates, involving research, innovation and education players who will have to compete globally for a reputation of excellence.
By providing Union funding for the best research and training programmes following the principles for innovative doctoral training in Europe, they will also promote wider dissemination and take-up, moving towards more structured doctoral training. Marie Skłodowska-Curie grants will also be extended to the temporary mobility of experienced researchers and engineers from public institutions to the private sector or vice versa, thereby encouraging and supporting universities, research centres and businesses, and other socio-economic actors to cooperate with one another on a European and international scale.
With the aid of their well-established, transparent and fair evaluation system, Marie Skłodowska-Curie actions will identify excellent talents in research and innovation in an international competition which gives prestige and therefore motivation for researchers to advance their career in Europe.